Cargando…
Design expert software assisted development and evaluation of empagliflozin and sitagliptin combination tablet with improved in-vivo anti-diabetic activities
BACKGROUND: The combination of empagliflozin and sitagliptin to treat type-2 diabetes might be more economical and patient compliance with an additive improvement in glycemic control due to complementary modes of action. AIM OF THE STUDY: To design, formulate and optimize an immediate tablet dosage...
Autores principales: | Hossain, Md Saddam, Jahan, Sadia, Al Rezwan Rahman, Sad, Rahman, Mashiur, Kumar, Diponkor, Paul, Susmita, Chandra Rajbangshi, Joy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015239/ https://www.ncbi.nlm.nih.gov/pubmed/36938401 http://dx.doi.org/10.1016/j.heliyon.2023.e14259 |
Ejemplares similares
-
Use of herbal medicines during pregnancy in a group of Bangladeshi women
por: Jahan, Sadia, et al.
Publicado: (2022) -
Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics
por: Htoo, Phyo T., et al.
Publicado: (2022) -
Antecedents and effect of creative accounting practices on organizational outcomes: Evidence from Bangladesh
por: Rahman, Muhammad Shajib, et al.
Publicado: (2023) -
Efficacy and safety of combination of empagliflozin and metformin with combination of sitagliptin and metformin during Ramadan: an observational study
por: Ahmed, Ibrar, et al.
Publicado: (2022) -
CELESTIA: Cost-Effectiveness Analysis of Empagliflozin Versus Sitagliptin in Patients with Type 2 Diabetes in Greece
por: Ghetti, Gianni, et al.
Publicado: (2023)